NCT06610825
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06610825
Title Castrate Resistant Prostate Cancer Enhertu Therapy (CaRPET)
Acronym CaRPET
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Washington D.C. Veterans Affairs Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.